Live Well, Start Now Live Well, Start Now
The FDA approved Roche's cobas BV/CV test for faster, accurate detection of bacterial vaginosis and Candida vaginitis from…
The FDA approves a new once-weekly contraceptive patch for women, offering a low-estrogen option with steady hormone delivery.…
Virtual pelvic health therapy delivers outcomes comparable to in-person care, challenging traditional rehabilitation assumptions.
Hospital teams are shifting from solo work to collaboration for better patient outcomes and efficiency in healthcare settings.
The FDA approved Roche's cobas BV/CV test for faster, accurate detection of bacterial vaginosis and Candida vaginitis from…
Remote ultrasound technology lets high‑risk pregnant women complete biophysical profiles at home, reducing clinic visits and improving care…
Virtual pelvic health therapy delivers outcomes comparable to in-person care, challenging traditional rehabilitation assumptions.
Literature lacks studies on black women endometriosis and preeclampsia, exposing a critical blind spot in medical research today.
Discover the new ACOG guidance on diagnosing and treating endometriosis without surgery. Learn how this changes patient care.
Revi Extend implantable tibial neuromodulation system treats urinary incontinence with 15-year device life span, gaining FDA clearance for…
Physicians can address women's sexual health using the Fourth Pillar framework immediately.
FDA approves Gwyn Lo patch for women with BMI under 30. Learn about this new contraceptive authorization and…
Researchers study prenatal care services offered by federally qualified health centers, focusing on prenatal care availability.
Explore the FDA approval of the once-weekly transdermal contraception patch for women with BMI under 30, offering a…
